Xeris Pharmaceuticals - Recruiting 18 years to 30 years. - A Randomized, Phase 2a, Blinded, 3-Way Crossover Dose-Ranging Study With G-Pen Miniâ¢ (Glucagon Injection) to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Patients With Type 1 Diabetes Mellitus (T1DM).
Katholieke Universiteit Leuven - Recruiting 18 years or older. - LOGIC-Insulin Computerized Algorithm-guided Versus Nurse-directed Blood Glucose Control in Critically Ill Patients: the LOGIC-2 Multicentre Randomized Controlled Trial.
high carbohydrate test meal; high carbohydrate test meal after pre-treatment with rapid acting aspart insulin; high fructose , low glucose test meal with carbohydrate and caloric content similar to the control meal